A Meta-Analysis of the Renal Safety of Isosmolar Iodixanol Compared With Low-Osmolar Contrast Media

Journal of the American College of Cardiology

Volumn 48, Issue 4, 2006, Pages 692-699

  McCullough, Peter A ^a   Bertrand, Michel E ^c   Brinker, Jeffrey A ^b   Stacul, Fulvio ^d  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIV LILLE   (France)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE; IODIXANOL;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTOGRAPHY; ARTICLE; BRAIN ANGIOGRAPHY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FEMORAL ANGIOGRAPHY; FREQUENCY ANALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NEPHROTOXICITY; OSMOLALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

CONTRAST MEDIA; CREATININE; DIABETES MELLITUS; HUMANS; KIDNEY DISEASES; OSMOLAR CONCENTRATION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TRIIODOBENZOIC ACIDS;

EID: 33644768605     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.02.073     Document Type: Article

References (48)

1. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
2. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention. incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
3. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
4. Shusterman N., Strom B.L., Murray T.G., Morrison G., West S.L., and Maislin G. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med 83 (1987) 65-71
5. Hou S.H., Bushinsky D.A., Wish J.B., Cohen J.J., and Harrington J.T. Hospital-acquired renal insufficiency. a prospective study. Am J Med 74 (1983) 243-248
6. Morcos S.K. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71 (1998) 357-365
7. Fried L.F., Shlipak M.G., Crump C., et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41 (2003) 1364-1372
8. Shulman N.B., Ford C.E., Hall W.D., et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13 (1989) I80-I93
9. Morcos S.K., Thomsen H.S., Webb J.A., Contrast Media Safety Committee, and European Society of Urogenital Radiology (ESUR). Contrast-media-induced nephrotoxicity. a consensus report. Eur Radiol 9 (1999) 1602-1613
10. Barrett B.J., Parfrey P.S., Vavasour H.M., et al. Contrast nephropathy in patients with impaired renal function. high versus low osmolar media. Kidney Int 41 (1992) 1274-1279
11. Manske C.L., Sprafka J.M., Strony J.T., and Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89 (1990) 615-620
12. Lindholt J.S. Radiocontrast induced nephropathy. Eur J Vasc Endovasc Surg 25 (2003) 296-304
13. Dawson P., and Howell M. The non-ionic dimers. a new class of contrast agents. Br J Radiol 59 (1986) 987-991
14. Deray G., Bellin M.F., Boulechfar H., et al. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency. comparison of low- and high-osmolar contrast agents. Am J Nephrol 11 (1991) 309-312
15. Campbell D.R., Flemming B.K., Mason W.F., Jackson S.A., Hirsch D.J., and MacDonald K.J. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography. Can Assoc Radiol J 41 (1990) 133-137
16. Nikonoff T., Skau T., Berglund J., Nyberg P., Spangberg-Viklund B., and Larsson R. Effects of femoral arteriography and low osmolar contrast agents on renal function. Acta Radiol 34 (1993) 88-91
17. King B., Segal A., and Berg G. Manual on Contrast Media. Version 5.0 (2004), American College of Radiology, Reston, VA
18. Chalmers N., and Jackson R.W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72 (1999) 701-703
19. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
20. Pugh N.D., Sissons G.R., Ruttley M.S., Berg K.J., Nossen J.O., and Eide H. Iodixanol in femoral arteriography (phase III). a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 47 (1993) 96-99
21. Hardiek K, Katholi R, Ogden C, Pianfetti L. Double-blind, randomized, comparison of iopamidol 370 and iodixanol 320: renal response in diabetic subjects (abstr). Paper presented at: Radiological Society of North America 89th Scientific Assembly and Annual Meeting; November 30-December 5, 2003; Chicago, IL.
22. Carraro M., Malalan F., Antonione R., et al. Effects of a dimeric vs. a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency. a double-blind, randomized clinical trial. Eur Radiol 8 (1998) 144-147
23. National Kidney Foundation. Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, Classification, and Stratification. Am J Kidney Dis 2 Suppl 1 (2002) S46-S75
24. Andersen P.E., Bolstad B., Berg K.J., Justesen P., Thayssen P., and Kloster Y.F. Iodixanol and ioxaglate in cardioangiography. a double-blind randomized phase III study. Clin Radiol 48 (1993) 268-272
25. Bertrand M.E., Esplugas E., Piessens J., Rasch W., and Visipaque in Percutaneous Transluminal Coronary Angioplasty VIP Trial Investigators. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty. a multicenter, randomized, double-blind study. Circulation 101 (2000) 131-136
26. Hill J.A., Cohen M.B., Kou W.H., et al. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. Am J Cardiol 74 (1994) 57-63
27. Kløw N.E., Levorstad K., Berg K.J., et al. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol 34 (1993) 72-77
28. Manninen H., Tahvanainen K., Borch K., et al. Iodixanol, a new non-ionic, dimeric contrast medium in cardioangiography. a double-masked, parallel comparison with iopromide. Eur Radiol 5 (1995) 364-370
29. Tveit K., Bolz K.D., Bolstad B., et al. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol 35 (1994) 614-618
30. Singh K., Sundgren R., Bolstad B., Bjork L., and Lie M. Iodixanol in abdominal digital subtraction angiography. A randomized, double-blind, parallel trial with iodixanol and iohexol. Acta Radiol 34 (1993) 242-245
31. Thorstensen O., Albrechtsson U., Calissendorff B., et al. Iodixanol in femoral arteriography. A randomized, double-blind, phase III, parallel study with iodixanol 270 mg I/ml and iohexol 300 mg I/ml. Acta Radiol 35 (1994) 629-631
32. Verow P., Nossen J.O., Sheppick A., and Kjaersgaard P. A comparison of iodixanol with iopamidol in aorto-femoral angiography. Br J Radiol 68 (1995) 973-978
33. Jakobsen J.A., Berg K.J., Kjaersgaard P., et al. Angiography with nonionic X-ray contrast media in severe chronic renal failure. renal function and contrast retention. Nephron 73 (1996) 549-556
34. Rosenblum J.D., Siegel E.L., Leef J., Eckard D.A., and Lu C.T. Iodixanol and ioxaglate in adult aortography and peripheral arteriography. a phase III clinical trial. Acad Radiol 3 Suppl 3 (1996) S514-S518
35. Siegel E.L., Rosenblum J.D., Eckard D.A., et al. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography. a phase III clinical trial. Acad Radiol 3 Suppl 3 (1996) S507-S513
36. Poirier V.C., Newberry P.D., Hecht S.T., and Nemzek W.R. Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography. Acad Radiol 3 Suppl 3 (1996) S495-S499
37. McCullough P.A., and Sandberg K.R. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 4 Suppl 5 (2003) S3-S9
38. Rudnick M.R., Goldfarb S., Wexler L., et al., The Iohexol Cooperative Study. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients. a randomized trial. Kidney Int 47 (1995) 254-261
39. Clauss W., Dinger J., and Meissner C. Renal tolerance of iotrolan 280- a meta analysis of 14 double-blind studies. Eur Radiol 5 (1995) S79-S84
40. Lim P., Mackie K., Ross J., Seidelin P., and Dzavik V. Contrast nephropathy and Visipaque use in routine clinical practice of percutaneous coronary intervention. insights from Toronto General Hospital PCI Registry. Circulation 110 (2004) III492
41. Parfrey P.S., Griffiths S.M., Barrett B.J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320 (1989) 143-149
42. Gussenhoven M.J., Ravensbergen J., van Bockel J.H., Feuth J.D., and Aarts J.C. Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease. J Cardiovasc Surg (Torino) 32 (1991) 81-86
43. Tadros G.M., Malik J.A., Manske C.L., et al. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. J Invasive Cardiol 17 (2005) 211-215
44. Brinker J. What every cardiologist should know about intravascular contrast. Rev Cardiovasc Med 4 Suppl 5 (2003) S19-S27
45. Kshirsagar A.V., Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy. a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15 (2004) 761-769
46. Gami A.S., and Garovic V.D. Contrast nephropathy after coronary angiography. Mayo Clin Proc 79 (2004) 211-219
47. Guitterez N.V., Diaz A., Timmis G.C., O'Neill W.W., Stevens M.A., Sandberg K.R., et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol 15 (2002) 349-354
48. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264